These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11284211)

  • 21. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
    Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Gonzalez-Padilla DA
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011281. PubMed ID: 26798030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Satisfaction and quality of life evaluation in patients with type 1 diabetes mellitus treated using continuous subcutaneous insulin infusion compared with multiple daily injections].
    Lozano-Serrano M; García-Seco JA; García-Seco F; Lozano-Hernández MC; Seco-Segura ÁM; Moreno-Fernández J; Muñoz-Cazallas PA; Ferreiro-Vicario C; Sánchez-Covisa MA
    Enferm Clin; 2013; 23(3):96-102. PubMed ID: 23755944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin lispro: a review of its use in the management of diabetes mellitus.
    Simpson D; McCormack PL; Keating GM; Lyseng-Williamson KA
    Drugs; 2007; 67(3):407-34. PubMed ID: 17335298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of glargine group-start sessions in patients with type 2 diabetes as a strategy to deliver the service.
    Tahrani AA; Digwood S; Lee C; Moulik P
    Int J Clin Pract; 2007 Feb; 61(2):329-35. PubMed ID: 17263721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ).
    Rubin RR; Peyrot M
    Health Qual Life Outcomes; 2010 Mar; 8():32. PubMed ID: 20334647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes.
    Witthaus E; Stewart J; Bradley C
    Diabet Med; 2001 Aug; 18(8):619-25. PubMed ID: 11553198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: a placebo-controlled, multicentre study.
    Bech P; Moses R; Gomis R
    Qual Life Res; 2003 Jun; 12(4):413-25. PubMed ID: 12797714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    ; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
    Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On calculating treatment satisfaction.
    Bradley C
    Diabetes Care; 1999 Oct; 22(10):1760. PubMed ID: 10526762
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin analogues and management of diabetes mellitus.
    Vaidyanathan B; Menon PS
    Indian J Pediatr; 2000 Jun; 67(6):435-41. PubMed ID: 10932964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Insulin Lispro (Lys B28, Pro B29) treatment in adolescents and young people with type 1 diabetes].
    Tuset Castellano MJ; Martínez Badás I; Alonso Blanco M; Barrio Castellanos R
    An Esp Pediatr; 2000 Apr; 52(4):334-8. PubMed ID: 11003924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes.
    Fineberg SE; Huang J; Brunelle R; Gulliya KS; Anderson JH
    Diabetes Care; 2003 Jan; 26(1):89-96. PubMed ID: 12502663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment satisfaction after commencement of insulin in Type 2 diabetes.
    Wilson M; Moore MP; Lunt H
    Diabetes Res Clin Pract; 2004 Dec; 66(3):263-7. PubMed ID: 15536023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment.
    Mita T; Katakami N; Takahara M; Kawashima M; Wada F; Akiyama H; Morita N; Kidani Y; Yajima T; Shimomura I; Watada H
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2424-2432. PubMed ID: 35857060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.
    Clark PE; Valentine V; Bodie JN; Sarwat S
    Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus.
    Tupola S; Komulainen J; Jääskeläinen J; Sipilä I
    Diabet Med; 2001 Aug; 18(8):654-8. PubMed ID: 11553203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life as a key indicator of patient satisfaction and treatment compliance in people with type 2 diabetes mellitus in the IMPROVE study: a multicentre, open label, non-randomised, observational trial.
    Mukherjee AK; Reddy VS; Shah S; Jhingan AK; Ramakrishnan P; Prusty V; Singh NS
    J Indian Med Assoc; 2009 Jul; 107(7):464-70. PubMed ID: 20112854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.
    Niskanen L; Jensen LE; Råstam J; Nygaard-Pedersen L; Erichsen K; Vora JP
    Clin Ther; 2004 Apr; 26(4):531-40. PubMed ID: 15189750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.